JPS6322025A - キョウチクトウ種抽出物からなる細胞増殖性疾患治療用組成物 - Google Patents

キョウチクトウ種抽出物からなる細胞増殖性疾患治療用組成物

Info

Publication number
JPS6322025A
JPS6322025A JP62116678A JP11667887A JPS6322025A JP S6322025 A JPS6322025 A JP S6322025A JP 62116678 A JP62116678 A JP 62116678A JP 11667887 A JP11667887 A JP 11667887A JP S6322025 A JPS6322025 A JP S6322025A
Authority
JP
Japan
Prior art keywords
extract
patient
oleander
treatment
cell proliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62116678A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0529332B2 (cg-RX-API-DMAC10.html
Inventor
フセイン・ジーヤ・オーゼル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS6322025A publication Critical patent/JPS6322025A/ja
Publication of JPH0529332B2 publication Critical patent/JPH0529332B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G01N33/5758—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP62116678A 1986-05-13 1987-05-13 キョウチクトウ種抽出物からなる細胞増殖性疾患治療用組成物 Granted JPS6322025A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86272086A 1986-05-13 1986-05-13
US862720 1986-05-13
US4843587A 1987-05-11 1987-05-11
US48435 1987-05-11

Publications (2)

Publication Number Publication Date
JPS6322025A true JPS6322025A (ja) 1988-01-29
JPH0529332B2 JPH0529332B2 (cg-RX-API-DMAC10.html) 1993-04-30

Family

ID=26726121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62116678A Granted JPS6322025A (ja) 1986-05-13 1987-05-13 キョウチクトウ種抽出物からなる細胞増殖性疾患治療用組成物

Country Status (14)

Country Link
US (1) US5135745A (cg-RX-API-DMAC10.html)
JP (1) JPS6322025A (cg-RX-API-DMAC10.html)
KR (1) KR880013565A (cg-RX-API-DMAC10.html)
CN (1) CN87104312A (cg-RX-API-DMAC10.html)
AU (1) AU626516B2 (cg-RX-API-DMAC10.html)
CA (1) CA1299100C (cg-RX-API-DMAC10.html)
DK (1) DK239687A (cg-RX-API-DMAC10.html)
FI (1) FI872106A7 (cg-RX-API-DMAC10.html)
IL (1) IL82516A0 (cg-RX-API-DMAC10.html)
IN (1) IN165073B (cg-RX-API-DMAC10.html)
MC (1) MC1811A1 (cg-RX-API-DMAC10.html)
NO (1) NO871978L (cg-RX-API-DMAC10.html)
NZ (1) NZ220295A (cg-RX-API-DMAC10.html)
PT (1) PT84857B (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005289963A (ja) * 2004-03-12 2005-10-20 Hokubu Norin Koto Gakko Koenkai 抗腫瘍剤
JP2007008879A (ja) * 2005-06-30 2007-01-18 Yanbaru Green Health:Kk 抗腫瘍剤及びこれを含有する食品
WO2008078362A1 (ja) * 2006-12-22 2008-07-03 The Institute Of Biological Resources 抗腫瘍剤及びこれを含有する食品

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003227319B2 (en) * 1998-09-24 2007-07-26 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
JP2002526452A (ja) 1998-09-24 2002-08-20 オゼル・ファーマスーティカルズ・インコーポレイテッド キョウチクトウ抽出物、その医薬組成物及びその調整方法
KR100478146B1 (ko) * 2002-08-30 2005-03-22 재단법인 포항산업과학연구원 협죽도과 식물의 잎 추출물을 함유하는 고려잔디갈색퍼짐병 방제용 조성물 및 이를 이용하여 갈색퍼짐병을방제하는 방법
US20050112059A1 (en) * 2003-10-06 2005-05-26 Phoenix Biotechnology, Inc. Enhancement of radiotherapy by an exogenous cardiac glycoside
WO2005060951A2 (en) * 2003-12-19 2005-07-07 Bionaut Pharmaceuticals, Inc. Anti-neoplastic agents, combination therapies and related methods
WO2006028969A1 (en) * 2004-09-02 2006-03-16 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using na+/k+ atpase inhibitors
US20070105790A1 (en) * 2004-09-02 2007-05-10 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using Na+/K+ ATPase inhibitors
EP1789090A2 (en) * 2004-09-02 2007-05-30 Bionaut Pharmaceuticals, Inc. Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors
US20080027010A1 (en) * 2004-09-02 2008-01-31 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using Na+/K+-ATPase inhibitors
US20060135468A1 (en) * 2004-09-02 2006-06-22 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using NA+/K+ ATPase inhibitors
US20060135443A1 (en) * 2004-10-18 2006-06-22 Bionaut Pharmaceuticals, Inc. Use of Na*/K*-ATPase inhibitors and antagonists thereof
US20060188536A1 (en) * 2005-02-15 2006-08-24 Phoenix Biotechnology Inc. Particles from processing of oleander leaves
US7402325B2 (en) * 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP1803461A1 (en) * 2005-12-27 2007-07-04 Heinz-Herbert Fiebig Therapeutic use of an extract from the leaves of Nerium oleander
US8486465B1 (en) * 2007-07-09 2013-07-16 Douglas CRAWFORD Therapeutic nerium oleander extract compositions and methods of using
CN101613414B (zh) * 2008-06-26 2011-09-07 中国科学院上海药物研究所 两种夹竹桃寡糖及其制备方法和用途
KR101717301B1 (ko) 2008-10-14 2017-03-16 네리엄 바이오테크놀로지, 인크. 강심 배당체의 추출방법 및 조성물
CN101416988B (zh) * 2008-12-07 2011-12-21 中国热带农业科学院热带生物技术研究所 采食长春花叶的夹竹桃天蛾幼虫粪便提取物在制备抗肿瘤药物中的用途
TR200900312A2 (tr) * 2009-01-15 2010-08-23 Levent Baş Ahmet Nerium oleander'in tip II diyabet, obezite, yüksek kolesterol ve trigliserid düzeyi ile seyreden hastalıklar ve kardiovasküler hastalıklarda kullanımı@
MX365635B (es) 2011-10-20 2019-06-10 Nerium Biotechnology Inc Combinacion terapeutica para el tratamiento de cancer.
WO2018053123A1 (en) 2016-09-14 2018-03-22 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
US10596186B2 (en) 2016-09-14 2020-03-24 Phoenix Biotechnology, Inc. Method and compositions for treating viral infections
US10729735B1 (en) 2016-09-14 2020-08-04 Phoenix Biotechnology, Inc. Method and compostitions for treating coronavirus infection
US10702567B2 (en) 2016-09-14 2020-07-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
JP6820450B2 (ja) 2017-09-14 2021-01-27 フェニックス・バイオテクノロジー・インコーポレイテッド ウイルス感染を治療するための方法および組成物
WO2021201903A1 (en) 2020-03-31 2021-10-07 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
AU2020220204B1 (en) * 2020-03-31 2021-03-25 Phoenix Biotechnology, Inc. Method and compositions for treating Coronavirus infection
US11806359B2 (en) 2020-03-31 2023-11-07 Phoenix Biotechnology, Inc. Method and compositions for treating Coronavirus infection
CN112689510B (zh) * 2020-03-31 2022-02-01 菲尼克斯生物技术公司 用于治疗冠状病毒感染的方法和组合物
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
US12097234B2 (en) 2020-05-24 2024-09-24 Phoenix Biotechnology, Inc. Extract containing oleandrin and method of production thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005289963A (ja) * 2004-03-12 2005-10-20 Hokubu Norin Koto Gakko Koenkai 抗腫瘍剤
JP2007008879A (ja) * 2005-06-30 2007-01-18 Yanbaru Green Health:Kk 抗腫瘍剤及びこれを含有する食品
WO2008078362A1 (ja) * 2006-12-22 2008-07-03 The Institute Of Biological Resources 抗腫瘍剤及びこれを含有する食品

Also Published As

Publication number Publication date
US5135745A (en) 1992-08-04
AU7278587A (en) 1987-11-19
MC1811A1 (fr) 1988-03-18
IN165073B (cg-RX-API-DMAC10.html) 1989-08-12
PT84857A (en) 1987-06-01
NO871978D0 (no) 1987-05-13
NZ220295A (en) 1990-04-26
JPH0529332B2 (cg-RX-API-DMAC10.html) 1993-04-30
CA1299100C (en) 1992-04-21
CN87104312A (zh) 1988-01-13
FI872106A0 (fi) 1987-05-12
NO871978L (no) 1987-11-16
FI872106L (fi) 1987-11-14
IL82516A0 (en) 1987-11-30
DK239687A (da) 1987-11-14
PT84857B (pt) 1990-02-08
KR880013565A (ko) 1988-12-21
AU626516B2 (en) 1992-08-06
FI872106A7 (fi) 1987-11-14
DK239687D0 (da) 1987-05-12

Similar Documents

Publication Publication Date Title
JPS6322025A (ja) キョウチクトウ種抽出物からなる細胞増殖性疾患治療用組成物
CN1073843C (zh) 熊果酸或其盐在制备抑制转移的药物中的应用
Cameron et al. A long-term follow-up of synovial sarcoma
Nunn On cancer of the breast
EP0246069B1 (en) Extracts of nerium species, methods of preparation, and use therefore
CN102755614B (zh) 一种多效穴位敷贴药膏及其制备方法
Henneford et al. The time of appearance of metastases after surgical removal of the primary tumor
CN104784627A (zh) 一种用于治疗外科开放性或闭合性损伤的中药外用膜剂及其制备方法
Bryant Suppurative pylephlebitis
CN1833687A (zh) 一种用于治疗消化性溃疡和慢性胃炎的中药组合物及其制备方法和其用途
Wenlong et al. A Case Report of A Successful Repair of Lesion of Metastatic in A Patient with Hepatocellular Carcinoma
SU1651781A3 (ru) Способ получени экстракта, обладающего противоопухолевой активностью
DOUMBIA et al. The Mediastinal Ganglioneuroma in a Case Operated on in Mali
Maske et al. STUDY OF EFFICACY OF KHADIRADI KWATH IN FISTULA-IN-ANO
Parsonage et al. Paraplegia following the use of “Efocaine”
CN120570886A (zh) 荜澄茄碱在治疗脑缺血再灌注损伤药物的应用及验证方法
CN119488512A (zh) 肉桂醇及其衍生物在制备预防或治疗肿瘤的药物中的应用
Greenough Essential Facts about Cancer: A Handbook for the Medical Profession
Herrmann ently most conducive to hypertrophy. The dogs with partial
Crile Problems in Surgery: University of Washington Graduate Medical Lectures, 1927
Chitre et al. Anacidity in gastric cancer
Harsha The Comparative Study of Darana Effect of Dantyadi Lepa and Marmani Lepa in Bahya Vidhradhi
following Gastro-enterostomy et al. EPITOMIE OF CURR. 1ENT MIEDICAL LITERATURE Medicine
Kirwan A Rare Cause of Foetal Death
GANGRENE VOLUME 8 OCTOBER, 1938

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080430

Year of fee payment: 15